{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:18:30Z","timestamp":1785280710657,"version":"3.55.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,11]]},"DOI":"10.1212\/wnl.47.5.1264","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:24:15Z","timestamp":1336915455000},"page":"1264-1268","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":73,"title":["Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine"],"prefix":"10.1212","volume":"47","author":[{"given":"Russell W.","family":"Hurd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Wilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendell R.","family":"Helveston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basim M.","family":"Uthman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410280102"},{"key":"e_1_3_1_3_2","first-page":"8","volume":"2","year":"1983","unstructured":"Eldridge R, Iivanainen M, Stern R, Koerber T, Wilder BJ. \"Baltic\" myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet 1983;2:838-842.","journal-title":"Lancet"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.1.1"},{"key":"e_1_3_1_5_2","first-page":"2","volume":"43","year":"1993","unstructured":"Lehesjoki AE, Eldridge R, Eldridge J, Wilder BJ, de la Chapelle A. Progressive myoclonus epilepsy of the Unverricht-Lundborg type: a clinical and molecular genetic study of a family from the United States with four affected sibs. Neurology 1993;43:2384-2386.","journal-title":"Neurology"},{"key":"e_1_3_1_6_2","first-page":"7","volume":"4","year":"1995","unstructured":"Yamakawa K, Mitchell S, Hubert R, et al. Isolation and characterization of a candidate gene for progressive myoclonus epilepsy on 21q22.3. Hum Mol Genet 1995;4:709-716.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_7_2","unstructured":"Hurd RW Wilder BJ Perchalski RJ. Increased extracellular superoxide dismutase in Baltic myoclonus [abstract]. Epilepsia 1993;34(Suppl 2):14-15."},{"key":"e_1_3_1_8_2","first-page":"7","volume":"4","year":"1985","unstructured":"Levanon D, Lieman-Hurwitz J, Dafni W, et al. Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu\/Zn superoxide dismutase. EMBO J 1985;4:77-84.","journal-title":"EMBO J"},{"key":"e_1_3_1_9_2","first-page":"9","volume":"89","year":"1992","unstructured":"Oury TD, Ho Y-S, Piantadosi CA, Crapo JD. Extracellular superoxide dismutase, nitric oxide, and central nervous system toxicity. Proc Natl Acad Sci USA 1992;89:9715-9719.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_10_2","first-page":"5","volume":"6","year":"1989","unstructured":"Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989;6:593-597.","journal-title":"Free Radic Biol Med"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Godson C Ryan MD Brady HR Bourke S Fitsgerald MX. Acute hypomagnesaemia complicating the treatment of meconium ileus equivalent in cystic fibrosis. Scand J Gastroenterol 1988;143(Suppl):148-150.","DOI":"10.3109\/00365528809090236"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004691-199101000-00002"},{"key":"e_1_3_1_13_2","first-page":"3","volume":"63","year":"1994","unstructured":"Gotz ME, Kunig G, Riederer P, Youdim MBH. Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 1994;63:37-122.","journal-title":"Pharmacol Ther"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(90)90219-K"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)42297-6"},{"key":"e_1_3_1_16_2","unstructured":"Hurd RW Perchalski RJ Wilder BJ Uthman BM Pippenger CE. The role of copper in the differing effects of valproic acid (VPA) and phenytoin (PHT) in progressive myoclonus epilepsy of the Unverricht-Lundborg type (PME-UL) [abstract]. Neurology 1994;44(Suppl 2):A295."},{"key":"e_1_3_1_17_2","first-page":"1","volume":"5","year":"1986","unstructured":"Taylor A, Ghose K. Diurnal variation of serum copper and zinc in epileptics receiving anticonvulsants. Hum Toxicol 1986;5:195-200.","journal-title":"Hum Toxicol"},{"key":"e_1_3_1_18_2","first-page":"4","volume":"26","year":"1989","unstructured":"Sorenson JRJ. Copper complexes offer a physiological approach to treatment of chronic diseases. Prog Med Chem 1989;26:439-568.","journal-title":"Prog Med Chem"},{"key":"e_1_3_1_19_2","unstructured":"Pippenger CE Meng X Rothner D et al. Free radical scavenging enzyme activity profiles in risk assessment of idiosyncratic drug reactions. In: Levy RH Penry JK eds. Idiosyncratic reactions to valproate: clinical risk patterns and mechanisms of toxicity. New York: Raven Press 1991:75-88."},{"key":"e_1_3_1_20_2","unstructured":"Kelloff DS Crowell JA Boone CW et al. Clinical development plan: N-acetylcysteine (NAC). J Cell Biochem Suppl 1994;20(Suppl 20):63-73."},{"key":"e_1_3_1_21_2","first-page":"5","volume":"42","year":"1988","unstructured":"Ziment I. Acetylcysteine: a drug that is much more than a mucokinetic. Biomed Pharmacother 1988;42:513-520.","journal-title":"Biomed Pharmacother"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000139022"},{"key":"e_1_3_1_23_2","first-page":"2","volume":"20","year":"1995","unstructured":"Cossarizza A, Franceschi C, Monti D, et al. Protective effect of N-acetylcysteine in tumor necrosis factor- alpha -induced apoptosis in U937 cells: the role of mitochondria. Exp Cell Res 1995;20:232-240.","journal-title":"Exp Cell Res"},{"key":"e_1_3_1_24_2","first-page":"H","volume":"266","year":"1994","unstructured":"Zhang H, Spapen H, Nguyen DN, Benlabed M, Buurman WA, Vincent J-L. Protective effects of N-acetyl-L-cysteine in endotoxemia. Am J Physiol 1994;266:H1746-H1754.","journal-title":"Am J Physiol"},{"key":"e_1_3_1_25_2","first-page":"7","volume":"91","year":"1994","unstructured":"Mayer M, Noble M. N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in-vitro. Proc Natl Acad Sci USA 1994;91:7496-7500.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_26_2","first-page":"3","volume":"62","year":"1994","unstructured":"Ratan RR, Murphy TH, Baraban JM. Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem 1994;62:376-379.","journal-title":"J Neurochem"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-03-j0001.1995"},{"key":"e_1_3_1_28_2","first-page":"5","volume":"27","year":"1985","unstructured":"Henderson P, Hale TW, Sherm S, Habersang RW. N-Acetylcysteine therapy of acute heavy metal poisoning in mice. Vet Hum Toxicol 1985;27:522-525.","journal-title":"Vet Hum Toxicol"},{"key":"e_1_3_1_29_2","first-page":"1","volume":"265","year":"1993","unstructured":"Boesgaard S, Aldershvile J, Poulsen HE, Christensen S, Dige-Petersen H, Giese J. N-Acetylcysteine inhibits angiotensin converting enzyme in vivo. J Pharmacol Exp Ther 1993;265:1239-1244.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.47.5.1264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:15:28Z","timestamp":1711534528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.47.5.1264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,11]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,11]]}},"alternative-id":["10.1212\/WNL.47.5.1264"],"URL":"https:\/\/doi.org\/10.1212\/wnl.47.5.1264","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,11]]}}}